2010-2020 年美国使用单剂量强力霉素预防莱姆病的情况。

IF 3.8 4区医学 Q2 IMMUNOLOGY

Open Forum Infectious Diseases Pub Date : 2024-10-29 eCollection Date: 2024-10-01 DOI:10.1093/ofid/ofae593

Grace E Marx, Alyssa Beck, Cate Corey, Candace C Fuller, Nicole Haug, Jenice S Ko, Dave Martin, Alison F Hinckley

{"title":"2010-2020 年美国使用单剂量强力霉素预防莱姆病的情况。","authors":"Grace E Marx, Alyssa Beck, Cate Corey, Candace C Fuller, Nicole Haug, Jenice S Ko, Dave Martin, Alison F Hinckley","doi":"10.1093/ofid/ofae593","DOIUrl":null,"url":null,"abstract":"Single-dose doxycycline after high-risk tick bites can prevent Lyme disease, which disproportionately affects children. We described single-dose doxycycline dispensings in an outpatient cohort in the United States. During 2010-2020, a total of 427 105 patients received ≥1 dispensing(s); most were aged ≥65 years. Lyme disease postexposure prophylaxis may be underprescribed for some groups, including children.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 10","pages":"ofae593"},"PeriodicalIF":3.8000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521345/pdf/","citationCount":"0","resultStr":"{\"title\":\"Lyme Disease Prophylaxis by Single-Dose Doxycycline in the United States, 2010-2020.\",\"authors\":\"Grace E Marx, Alyssa Beck, Cate Corey, Candace C Fuller, Nicole Haug, Jenice S Ko, Dave Martin, Alison F Hinckley\",\"doi\":\"10.1093/ofid/ofae593\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Single-dose doxycycline after high-risk tick bites can prevent Lyme disease, which disproportionately affects children. We described single-dose doxycycline dispensings in an outpatient cohort in the United States. During 2010-2020, a total of 427 105 patients received ≥1 dispensing(s); most were aged ≥65 years. Lyme disease postexposure prophylaxis may be underprescribed for some groups, including children.\",\"PeriodicalId\":19517,\"journal\":{\"name\":\"Open Forum Infectious Diseases\",\"volume\":\"11 10\",\"pages\":\"ofae593\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2024-10-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521345/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Forum Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ofid/ofae593\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Forum Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ofid/ofae593","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

被高危蜱虫叮咬后服用单剂量强力霉素可预防莱姆病，而莱姆病对儿童的影响尤为严重。我们描述了美国门诊病人队列中的单剂量强力霉素配药情况。2010-2020 年间，共有 427 105 名患者接受了≥1 次配药；大多数患者的年龄≥65 岁。莱姆病暴露后预防可能对包括儿童在内的某些群体处方不足。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Lyme Disease Prophylaxis by Single-Dose Doxycycline in the United States, 2010-2020.

Single-dose doxycycline after high-risk tick bites can prevent Lyme disease, which disproportionately affects children. We described single-dose doxycycline dispensings in an outpatient cohort in the United States. During 2010-2020, a total of 427 105 patients received ≥1 dispensing(s); most were aged ≥65 years. Lyme disease postexposure prophylaxis may be underprescribed for some groups, including children.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Open Forum Infectious Diseases Medicine-Neurology (clinical)

CiteScore

6.70

自引率

4.80%

发文量

630

审稿时长

9 weeks

期刊介绍： Open Forum Infectious Diseases provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment. The journal reflects the broad diversity of the field of infectious diseases, and focuses on the intersection of biomedical science and clinical practice, with a particular emphasis on knowledge that holds the potential to improve patient care in populations around the world. Fully peer-reviewed, OFID supports the international community of infectious diseases experts by providing a venue for articles that further the understanding of all aspects of infectious diseases.